EFI Lake Geneva Ventures is a seed and early-stage investment strategy based in Geneva, Switzerland. Founded in 2020, our mission is to foster innovation by investing at an early stage in fast-growing innovative Swiss companies in Technology, Life Sciences and Medtech.
Location: Switzerland, Geneva
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 23
Date | Name | Website | Total Raised | Location |
10.01.2024 | Hemotune | hemotune.c... | $13.17M | - |
27.10.2023 | nsave | nsave.com | - | United Kin... |
10.07.2023 | Impossible... | impossible... | $6.05M | United Kin... |
05.04.2023 | Impossible... | impossible... | $3.8M | - |
- | Aptissen S... | aptissen.c... | - | Switzerlan... |
- | Kejako | kejako.com | - | - |
- | Faitron | faitron.co... | - | Switzerlan... |
- | CELLnTEC A... | cellntec.c... | - | Switzerlan... |
- | EBAMed | eba-med.co... | $16.94M | Switzerlan... |
- | Abionic SA | abionic.co... | $24.94M | Switzerlan... |
Show more
Mentions in press and media 6
Date | Title | Description | Source |
25.03.2024 | CHF 14 million to fund hemotune’s clinical trials | The HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads, ... | startuptic... |
05.09.2023 | Hylomorph secures CHF 4.5m ahead of market launch | startuptic... | |
28.06.2023 | EUR 14.35 million to advance cardiac radiation ablation ther... | startuptic... | |
05.04.2023 | CHF 3.4 million to accelerate Impossible Materials market en... | startuptic... | |
01.03.2023 | FluoSphera secures $1 million pre-seed investment | startuptic... | |
17.02.2023 | CHF 2.3M to market Terapet first product and boost R&D | startuptic... |